Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Jan 1;35(1):63-72.
doi: 10.1097/QAD.0000000000002709.

Asymptomatic neurocognitive impairment is a risk for symptomatic decline over a 3-year study period

Sean B Rourke  1   2 , Tsegaye Bekele  3 , Anita Rachlis  4   5 , Colin Kovacs  6 , Jason Brunetta  6 , M John Gill  7   8 , Adriana Carvalhal  2   9 , Lucette A Cysique  1   10   11 , Thomas Marcotte  12   13 , Christopher Power  7   14
Affiliations

Asymptomatic neurocognitive impairment is a risk for symptomatic decline over a 3-year study period

Sean B Rourke et al. AIDS. .

Abstract

Objective: To examine whether persons with asymptomatic neurocognitive impairment (ANI) were more likely to show progression to mild neurocognitive disorder or HIV-associated dementia than those who were neuropsychologically normal (NP-N).

Design: Longitudinal observational cohort study.

Methods: Study sample included 720 HIV-1 seropositive persons (317 with ANI and 403 NP-N) receiving care in Toronto, Canada [83% were on antiretroviral treatment; 71% had undetectable (<50 copies/ml) plasma HIVRNA]. Neuropsychological assessments were conducted at 12 months intervals for a median follow-up time of 34 months. Neuropsychological data were corrected for age, education, sex, and race/ethnicity, and corrected for practice effect at follow-ups. Progression to mild neurocognitive disorder and HIV-associated dementia at each time point was determined using the Global Deficit Score and presence of cognitive symptoms.

Results: Over the follow-up period, 170 individuals (24%) progressed to symptomatic HIV-associated neurocognitive disorders (HAND). Persons with ANI were more likely to progress to symptomatic HAND than persons with NP-N after adjusting for baseline and time-varying confounders (adjusted hazards ratio: 1.88; 95% confidence interval: 1.37-2.60; P < 0.001). Female sex, depression, and cigarette smoking were associated with higher risk of progression to symptomatic HAND, but traditional HIV markers and antiretroviral treatment were not.

Conclusion: ANI is associated with a two-fold increased risk of progression to symptomatic HAND in a cohort with universal healthcare access. This represents the largest replication of comparable US results. Reproducibility of these findings indicate that routine monitoring of persons with ANI and exploration of clinical interventions to prevent or delay progression to symptomatic HAND are imperative.

Search terms: HIV, HAND, HIV-associated dementia, cohort study, replicability, reproducibility.

PubMed Disclaimer

Comment in

References

    1. Heaton R, Clifford D, Franklin D Jr, Woods S, Ake C, Vaida F, et al. HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy . Neurology 2010; 75:2087–2096.
    1. Torti C, Focà E, Cesana BM, Lescure FX. Asymptomatic neurocognitive disorders in patients infected by HIV: fact or fiction? . BMC Med 2011; 9:138.
    1. Grant I, Franklin DR, Deutsch R, Woods SP, Vaida F, Ellis RJ, et al. Asymptomatic HIV-associated neurocognitive impairment increases risk for symptomatic decline . Neurology 2014; 82:2055–2062.
    1. Sacktor N, Skolasky RL, Seaberg E, Munro C, Becker JT, Martin E, et al. Prevalence of HIV-associated neurocognitive disorders in the Multicenter AIDS Cohort Study . Neurology 2016; 86:334–340.
    1. Avidan MS, Ioannidis JPA, Mashour GA. Independent discussion sections for improving inferential reproducibility in published research . Br J Anaesth 2019; 122:413–420.

Publication types